15 Oct Shockwave Therapy recruits stem cells to the treated site
Shockwave therapy broadens its applications based on scientific evidence from clinical trials and the recognition of its activity. Its biological mechanism is capable of recruiting mesenchymal progenitor cells to the treated part.
Shockwave therapy has become established for pseudo-arthrosis, calcifying and chronic tendinopathies as well as plantar fasciitis. Shockwave therapy for venous, arterial and diabetic foot ulcers is also one of the most recently discovered applications. Studies are currently underway on its potential for maxillofacial surgery and bone regeneration following apicoectomies or cysts of the maxilla.